Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
08/2007
08/30/2007WO2006099005A8 Method for identifying agents which modulate gtpase activity involved in insulin-stimulated glut4 translocation
08/30/2007WO2006028561A3 Novel purified fabi polypeptides from fransicella tularensis
08/30/2007WO2005054480A3 Insect resistant cotton plants and methods of detecting the same
08/30/2007WO2005037856A3 Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
08/30/2007WO2005023203A3 Transition state analog inhibitors of ricin a-chain
08/30/2007WO2004048540A3 Mracs as modifiers of the rac pathway and methods of use
08/30/2007WO2004013346A8 Methods and compositions for genotyping
08/30/2007WO2004009836A3 Pr/set-domain containing nucleic acids, polypeptides, antibodies and methods of use
08/30/2007US20070204368 Banana Resistance Genes And Uses Thereof
08/30/2007US20070204366 Methods of seed breeding using high throughput nondestructive seed sampling
08/30/2007US20070204355 Transformed plant or fish cells with the isolated polynucleotide; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein
08/30/2007US20070203747 E-commerce systems and methods
08/30/2007US20070203327 Transcription factor of MHC class II genes, substances capable of inhibiting this transcription factor and medical uses of these substanaces
08/30/2007US20070203326 Integrin-linked kinase and its uses
08/30/2007US20070203088 Detection and modulation of IAPs and NAIP for the diagnosis and treatment of proliferative disease
08/30/2007US20070203084 Interfering Rna Duplex Having Blunt-Ends And 3'-Modifications
08/30/2007US20070203083 Methods Of Regulating Metabolism And Mitochondrial Function
08/30/2007US20070203082 RNAI Agents For Anti-SARS Coronavirus Therapy
08/30/2007US20070203070 28 human secreted proteins
08/30/2007US20070203061 Adiponectin expression-inducing agents and uses thereof
08/30/2007US20070202576 Labeled-imidazole-Polyethylene glycol compounds; nonpurine- and nonpyrimidine-based nucleotides; nucleotide sequence detectors; polymerization in the presence of deoxynucleotidyl transferase
08/30/2007US20070202572 Microorganisms for therapy
08/30/2007US20070202567 Diagnostics And Therapeutics For Diseases Associated With Arginyl Aminopeptidase Rnpep (Rnpep)
08/30/2007US20070202566 Hydrolases, Nucleic Acids Encoding Them And Methods For Making And Using Them
08/30/2007US20070202565 Growth plotter
08/30/2007US20070202564 Microbial streaking device
08/30/2007US20070202563 hydrolase enzymes useful for degrading and analyzing polysaccharides such as glycosaminoglycans including chondroitin sulfate, dermatan sulfate, unsulfated chondroitin and hyaluronan; promotere of nerve regeneration, stroke recovery, treating spinal cord injury,epithelial disease, infections and cancers
08/30/2007US20070202562 Flux limiting membrane for intravenous amperometric biosensor
08/30/2007US20070202561 Electronic Detection Immunoassays that Utilize a Binder Support Medium
08/30/2007US20070202560 Resin microchannel array, method of manufacturing the same and blood test method using the same
08/30/2007US20070202559 Chemical sensor enhanced by direct coupling of redox enzyme to conductive surface
08/30/2007US20070202555 Method for judging feature of malignant tumor
08/30/2007US20070202548 Screening assay to identify inhibitors of the murd enzyme using an activator-independent murd enzyme
08/30/2007US20070202544 Methods For Diagnosing And Treating Endoplasmic Reticulum (er) Stress Diseases
08/30/2007US20070202540 Tape stripping methods for analysis of skin disease and pathological skin state
08/30/2007US20070202539 Methods for quantitative proteome analysis of glycoproteins
08/30/2007US20070202534 CD38 as a prognostic indicator in B cell chronic lymphocytic leukemia
08/30/2007US20070202533 High speed DNA sequencer and method
08/30/2007US20070202532 Nucleic acid purification method and purification apparatus
08/30/2007US20070202531 Thermal Cycling Device
08/30/2007US20070202530 Devices And Methods For Isolating And Recovering Target Cells
08/30/2007US20070202529 Mixture comprising multisubunit polymerase for propagation and preparation of reporter probes; gene expression analysis
08/30/2007US20070202528 Methods for modulating proteins not previously known as proteases
08/30/2007US20070202527 using animal derived component free (ADCF) cell culture technology; attaching ADCF-adapted cells to microcarrier including an attachment mechanism for attaching filipodia of the cells, growing the cells in ADCF maintenance media, infecting with vaccine media, producing virus within cells, and harvesting
08/30/2007US20070202526 Genotyping result evaluation method and system
08/30/2007US20070202525 Non-invasive fetal genetic screening by digital analysis
08/30/2007US20070202524 Targeted Vectors
08/30/2007US20070202523 autocatalytic synthesis of multiple copies of a target nucleic acid sequence; efficient, while reducing the appearance of by-products
08/30/2007US20070202522 Isothermal screening of tumor cell related nucleic acids
08/30/2007US20070202521 Single Molecule DNA Sequencing Using Fret Based Dynamic Labeling
08/30/2007US20070202520 Novel lipase
08/30/2007US20070202519 Domain segmentation and analysis
08/30/2007US20070202518 Physiogenomic method for predicting statin injury to muscle and muscle side effects
08/30/2007US20070202517 Novel acid detection assays employing blocker oligonucleotides
08/30/2007US20070202516 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
08/30/2007US20070202515 Promac signature application
08/30/2007US20070202514 Detecting a target nucleic acid in a biological sample using RNA amplification; diagnosing a genetic disease, chromosomal abnormality; a predisposition to a disease or condition, infection by a pathogenic organism, determining identity or heredity
08/30/2007US20070202513 Using shed cellular material as evaluative indicator of cell proliferative disorders
08/30/2007US20070202512 Human single nucleotide polymorphisms associated with dose-dependent weight gain and methods of use thereof
08/30/2007US20070202511 Methods and compositions for the rapid isolation of small RNA molecules
08/30/2007US20070202510 Methods for diagnosing and treating kidney cancer
08/30/2007US20070202509 Microarray having a base cleavable sulfonyl linker
08/30/2007US20070202508 Novel thermophilic proteins and the nucleic acids encoding them
08/30/2007US20070202507 amplification of the 42-kDa C-terminal region of the MSP1 gene by using the PCR technique in the presence of digoxigenin-11-dUTP and the synthesis of the specific biotin labeled nucleotide probes directed to the 42-kDa C-terminal region of the MSP1 gene
08/30/2007US20070202506 Single nucleotide polymorphisms predicting cardiovascular disease
08/30/2007US20070202505 Methods for gene function analysis
08/30/2007US20070202504 Method Of Searching Specific Base Sequence
08/30/2007US20070202503 Pharmaceutical Composition Of (+)-Erythro-Mefloquine And Its Use
08/30/2007US20070202502 Assay For Bipolar Affective Disorder
08/30/2007US20070202501 Proteins Expressed In Ink Cells
08/30/2007US20070202500 Acylglycerol Acyltransferase-Like Protein Mgat-X2 And Uses Thereof
08/30/2007US20070202499 Methylated Gene Biomarkers For Detecting Cancer
08/30/2007US20070202498 comprising at least two chemically different fluorophores, providing a donor and an acceptor respectively, connected together by at least one linker moiety and bonded to a binder moiety; obtaining fluorescence enhancement by energy transfer enabled with binder molecules in diagnostic applications
08/30/2007US20070202497 One Step Oligochromatographic Device And Method Of Use
08/30/2007US20070202496 Liver cancer biomarkers
08/30/2007US20070202495 Use of resistive-pulse sensing with submicrometer pores or nanopores for the detection of the assembly of submicrometer or nanometer sized objects
08/30/2007US20070202494 Development of diagnostic kit for the detection of Chrysanthemum virus B
08/30/2007US20070202493 Device and method for maintaining a plurality of beads in suspension
08/30/2007US20070202492 Viral Assay
08/30/2007US20070202491 comparing the marker analytes from the affected areas with the marker analytes from the control area; for consumer products such as those which are topically applied, inhaled, swallowed, ingested, inserted rectally, etc
08/30/2007US20070202490 Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue
08/30/2007US20070202489 comparing the marker analytes from the affected areas with the marker analytes from the control area; for consumer products such as those which are topically applied, inhaled, swallowed, ingested, inserted rectally, etc
08/30/2007US20070202488 harvesting skin tissue from an animal, then identifying marker analyte selected from melanocyte stimulating hormone, microtubules composed of tubulin and associated proteins, and tyrosinases, and evaluating the effect of said test product on the tissue
08/30/2007US20070202487 Assay for phospholipidosis
08/30/2007US20070202486 Method Of Assaying Substance Capable Of Changing Mitochondrial Membrane Potential
08/30/2007US20070202128 Immunomodulatory oligonucleotides
08/30/2007US20070202127 comprise DP178 peptide corresponding to amino acids 638 to 673 of the HIV-1LAI gp41 protein; inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells
08/30/2007US20070202123 Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids
08/30/2007US20070202122 Non-splicing variants of gp350/220
08/30/2007US20070202121 SPAS-1 cancer antigen
08/30/2007US20070202120 Yellow Fever Mosquito Deoxyribonucleoside Kinases And Its Use
08/30/2007US20070202119 Method Of Therapy
08/30/2007US20070202118 Novel peroxiredoxin defense system from mycobacterium tuberculosis
08/30/2007US20070202115 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
08/30/2007US20070202114 Higher gene expression in sample indicates tumor is tamoxifen-resistant; drug screening
08/30/2007US20070202109 Method Of Diagnosing Breast Cancer
08/30/2007US20070202107 Novel kinases
08/30/2007US20070202106 Compositions and methods for the treatment of cancer
08/30/2007US20070202100 Using programmed death-1 (PD-1) protein as evaluative tool to identify modulators for treatment and prevention of nervous system, autoimmune, cell proliferative and allergic disorders
08/30/2007US20070202085 Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients